Infectious Diseases News and Research

RSS

Initial stages of breast cancer could be detected more accurately with new proteomics-based technology

Breast cancer, even at its initial stages, could be detected earlier and more accurately than current techniques using blood samples and a unique proteomics-based technology, according to findings of a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.

26 Jan 2021

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

Researchers in the United States have conducted a study showing that Moderna’s mRNA-1273 vaccine neutralizes all circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tested to date.

26 Jan 2021

‘We’re not controlling it in our schools’: Covid safety lapses abound across US

Computer science teacher Suzy Lebo saw covid-19 dangers frequently in her Indiana high school: classes with about 30 students sitting less than 18 inches apart. Students crowding teachers in hallways. Students and staff members taking off their masks around others.

26 Jan 2021

Study: Armed conflict affects health needs of at least 630 million women, children

Armed conflicts are becoming increasingly complex and protracted and a growing threat to humanitarian access and the delivery of essential health services, affecting at least 630 million women and children--over 8% of the world's population--in 2017.

24 Jan 2021

Second-generation double antibody protects from SARS-CoV-2 and its tested variants

The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation 'double antibody' that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy.

24 Jan 2021

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

Many college students fully recover from infectious mononucleosis (which is almost always caused by Epstein-Barr virus) within 1-6 weeks, but some go on to develop chronic fatigue syndrome, also called myalgic encephalomyelitis (ME/CFS).

22 Jan 2021

NCCN provides new guidance for COVID-19 vaccinations in people with cancer

The National Comprehensive Cancer Network put out new information today to provide guidance for COVID-19 vaccinations in people with cancer.

22 Jan 2021

A traditional Chinese medicine could help treat COVID‐19 symptoms

A team of researchers in China – at Guangzhou University of Chinese Medicine and Yunnan University of Chinese Medicine – recently explored the therapeutic properties of Yinqiao powder in treating COVID-19 symptoms. Their findings were recently published in Phytotherapy Research.

22 Jan 2021

New SERS-based sensor can detect influenza A viral pathogens with high reproducibility

Respiratory diseases like influenza can spread rapidly and escalate to global health crises. Thus, to control them, simple yet sensitive detection techniques are needed. Surface-enhanced Raman scattering (SERS) is a potential candidate but currently lacks reproducibility.

22 Jan 2021

FDA approves first injectable, complete regimen for HIV-1 infection in adults

The U.S. Food and Drug Administration today approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

21 Jan 2021

New multidisciplinary center to study origin and course of infectious diseases

The University of Bern is establishing a multidisciplinary center to study the origin and course of infectious diseases and their impact on health, society and economics. The new research center is to receive some 30 million Swiss Francs financial support from the Vinetum Foundation over a period of 10 years.

20 Jan 2021

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.

20 Jan 2021

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armored immune cells that can attack recurring cancer in liver transplant patients, while temporarily evading immunosuppressant drugs patients take to avoid organ rejection.

19 Jan 2021

Wuhan study has important implications for managing COVID-19 pandemic

Researchers in China and the United States have conducted a study assessing the household transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has important implications for managing the coronavirus disease 2019 (COVID-19) pandemic.

19 Jan 2021

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

A new study by researchers at Northwestern University Feinberg School of Medicine, USA, shows that antibiotic regimens for critically ill COVID-19 patients with bacterial superinfections may be promoting an unnecessarily high.

19 Jan 2021

World Health Assembly calls for urgent action on prevention and control of meningitis

At the 73rd Session of the World Health Assembly, Member States overwhelmingly endorsed a resolution calling for urgent action on meningitis prevention and control through the implementation of a bold, comprehensive global roadmap to defeat meningitis by 2030.

18 Jan 2021

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

A new study suggests that modified natural killer cells, which express a chimeric antigen receptor using S309 antibody, can bind to and inactivate SARS-CoV-2 spike protein in vitro.

18 Jan 2021

Newly-identified nutrient helps the gut recall prior infections and kill invading bacteria

Scientists studying the body's natural defenses against bacterial infection have identified a nutrient--taurine--that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn).

16 Jan 2021

Combination therapy reduces recovery time in COVID-19 patients, clinical trial finds

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

16 Jan 2021

Study shows why antihistamine drugs fail to control severe itch in eczema patients

In addition to a skin rash, many eczema sufferers also experience chronic itching, but sometimes that itching can become torturous. Worse, antihistamines -- the standard treatment for itching and allergy -- often don't help.

15 Jan 2021

Infectious Diseases News and Research

Initial stages of breast cancer could be detected more accurately with new proteomics-based technology

Moderna vaccine fully neutralizes new SARS-CoV-2 variants, study shows

‘We’re not controlling it in our schools’: Covid safety lapses abound across US

Study: Armed conflict affects health needs of at least 630 million women, children

Second-generation double antibody protects from SARS-CoV-2 and its tested variants

Study examines risk factors for developing ME/CFS in college students after infectious mononucleosis

NCCN provides new guidance for COVID-19 vaccinations in people with cancer

A traditional Chinese medicine could help treat COVID‐19 symptoms

New SERS-based sensor can detect influenza A viral pathogens with high reproducibility

FDA approves first injectable, complete regimen for HIV-1 infection in adults

New multidisciplinary center to study origin and course of infectious diseases

Immune systems of COVID-19 patients may rely on antibodies from earlier coronaviruses

Researchers design armored immune cells to attack recurring cancer in liver transplant patients

Wuhan study has important implications for managing COVID-19 pandemic

Are antibiotic regimens for critical COVID-19 patients with bacterial superinfection unnecessarily high?

World Health Assembly calls for urgent action on prevention and control of meningitis

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Newly-identified nutrient helps the gut recall prior infections and kill invading bacteria

Combination therapy reduces recovery time in COVID-19 patients, clinical trial finds

Study shows why antihistamine drugs fail to control severe itch in eczema patients

eBook: Advancing infectious disease vaccine development eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News